Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis
Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces...
Dunk MS Hosts Annual Charity Event in Partnership With UCLA Athletics and UCLA Health to Support MS Research
Dunk MS, the annual charity event showcasing the world's top pro dunkers, will take place at UCLA's legendary Pauley Pavilion on Saturday, May 18th. The...
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-DETECT aims to...